These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 31978169)

  • 1. Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients.
    Baier C; Linke L; Eder M; Schwab F; Chaberny IF; Vonberg RP; Ebadi E
    PLoS One; 2020; 15(1):e0227772. PubMed ID: 31978169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Rates of Central Line-Associated Bloodstream Infections in Patients With 1 vs 2 Central Venous Catheters.
    Dube WC; Jacob JT; Zheng Z; Huang Y; Robichaux C; Steinberg JP; Fridkin SK
    JAMA Netw Open; 2020 Mar; 3(3):e200396. PubMed ID: 32129868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic central line-associated bloodstream infections in children implanted with long term indwelling central venous catheters in a teaching hospital, Sri Lanka.
    Jayaweera JAAS; Sivakumar D
    BMC Infect Dis; 2020 Jun; 20(1):457. PubMed ID: 32600427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a bundle of measures for reducing central line-associated bloodstream infections.
    Hernández-Aceituno A; Vega-Costa V; Ruiz-Álvarez M; Figuerola-Tejerina A; Méndez-Hernández R; Ramasco-Rueda F
    Rev Esp Anestesiol Reanim (Engl Ed); 2020 May; 67(5):227-236. PubMed ID: 32216956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis.
    Yamaguchi RS; Noritomi DT; Degaspare NV; Muñoz GOC; Porto APM; Costa SF; Ranzani OT
    Intensive Care Med; 2017 Aug; 43(8):1097-1104. PubMed ID: 28584925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of multiple concurrent central venous catheters on central line-associated bloodstream infections.
    Concannon C; van Wijngaarden E; Stevens V; Dumyati G
    Infect Control Hosp Epidemiol; 2014 Sep; 35(9):1140-6. PubMed ID: 25111922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings.
    Ardura MI; Bibart MJ; Mayer LC; Guinipero T; Stanek J; Olshefski RS; Auletta JJ
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e64-e72. PubMed ID: 32960848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attributable cost and length of stay for central line-associated bloodstream infections.
    Goudie A; Dynan L; Brady PW; Rettiganti M
    Pediatrics; 2014 Jun; 133(6):e1525-32. PubMed ID: 24799537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections.
    Stevens V; Geiger K; Concannon C; Nelson RE; Brown J; Dumyati G
    Clin Microbiol Infect; 2014 May; 20(5):O318-24. PubMed ID: 24112305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients.
    Kelly M; Conway M; Wirth K; Potter-Bynoe G; Billett AL; Sandora TJ
    Infect Control Hosp Epidemiol; 2011 Nov; 32(11):1079-85. PubMed ID: 22011534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLABSI Risk Factors in the NICU: Potential for Prevention: A PICNIC Study.
    Dahan M; O'Donnell S; Hebert J; Gonzales M; Lee B; Chandran AU; Woolsey S; Escoredo S; Chinnery H; Quach C
    Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1446-1452. PubMed ID: 27609629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central-line associated bloodstream infections in a tertiary care children's University hospital: a prospective study.
    Venturini E; Montagnani C; Benni A; Becciani S; Biermann KP; De Masi S; Chiappini E; de Martino M; Galli L;
    BMC Infect Dis; 2016 Dec; 16(1):725. PubMed ID: 27903240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the multimodal intervention including an automatic notification of catheter days on reducing central line-related bloodstream infection: a retrospective, observational, quasi-experimental study.
    Bae S; Kim Y; Chang HH; Kim S; Kim HJ; Jeon H; Cho J; Lee J; Chae H; Han G; Kim SW
    BMC Infect Dis; 2022 Jul; 22(1):604. PubMed ID: 35804323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing Patients Presenting on Hospital Admission With Central Line-Associated Bloodstream Infections: A Multicenter Study.
    Oladapo-Shittu O; Cosgrove SE; Rock C; Hsu YJ; Klein E; Harris AD; Mejia-Chew C; Saunders H; Ching PR; Gadala A; Mayoryk S; Pineles L; Maragakis L; Salinas A; Helsel T; Keller SC
    Clin Infect Dis; 2024 Jun; 78(6):1632-1639. PubMed ID: 38483930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study.
    Pitiriga V; Bakalis J; Kampos E; Kanellopoulos P; Saroglou G; Tsakris A
    Antimicrob Resist Infect Control; 2022 Jul; 11(1):96. PubMed ID: 35841083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for central line-associated bloodstream infection in pediatric intensive care units.
    Wylie MC; Graham DA; Potter-Bynoe G; Kleinman ME; Randolph AG; Costello JM; Sandora TJ
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1049-56. PubMed ID: 20731595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence rate and risk factors of central line-associated bloodstream infections among neonates and children admitted to a tertiary care university hospital.
    Khieosanuk K; Fupinwong S; Tosilakul A; Sricharoen N; Sudjaritruk T
    Am J Infect Control; 2022 Jan; 50(1):105-107. PubMed ID: 34348119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency Department Central Line-associated Bloodstream Infections (CLABSI) Incidence in the Era of Prevention Practices.
    Theodoro D; Olsen MA; Warren DK; McMullen KM; Asaro P; Henderson A; Tozier M; Fraser V
    Acad Emerg Med; 2015 Sep; 22(9):1048-55. PubMed ID: 26336036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors for central vascular catheter-related bloodstream infections in a tertiary care hospital.
    Tarpatzi A; Avlamis A; Papaparaskevas J; Daikos GL; Stefanou I; Katsandri A; Vasilakopoulou A; Chatzigeorgiou KS; Petrikkos GL
    New Microbiol; 2012 Oct; 35(4):429-37. PubMed ID: 23109010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy.
    Tsai HC; Huang LM; Chang LY; Lee PI; Chen JM; Shao PL; Hsueh PR; Sheng WH; Chang YC; Lu CY
    J Microbiol Immunol Infect; 2015 Dec; 48(6):639-46. PubMed ID: 25311403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.